| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 3 months | ₹15,000 | ₹14,898 | -0.68% | |
| 6 months | ₹30,000 | ₹30,692 | +2.31% | |
| 1 year | ₹60,000 | ₹61,219 | +2.03% | |
| 3 years | ₹1,80,000 | ₹1,87,813 | +4.34% |
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Bosch Ltd | Consumer Discretionary | Equity | 6.58% |
| Pidilite Industries Ltd | Materials | Equity | 5.81% |
| Akzo Nobel India Ltd | Materials | Equity | 5.08% |
| Hero Motocorp Ltd | Consumer Discretionary | Equity | 5.06% |
| Mphasis Ltd | Technology | Equity | 5.05% |
| Marico Ltd | Consumer Staples | Equity | 5.01% |
| ABB India Ltd | Industrials | Equity | 5.00% |
| AU Small Finance Bank Ltd | Financial | Equity | 4.94% |
| Page Industries Ltd | Consumer Discretionary | Equity | 4.61% |
| Britannia Industries Ltd | Consumer Staples | Equity | 4.35% |
| Bayer CropScience Ltd | Materials | Equity | 3.95% |
| The Great Eastern Shipping Company Ltd | Energy & Utilities | Equity | 3.91% |
| Dr. Lal Pathlabs Ltd | Healthcare | Equity | 3.82% |
| Crisil Ltd | Industrials | Equity | 3.62% |
| Rainbow Childrens Medicare Ltd | Healthcare | Equity | 3.52% |
| Can Fin Homes Ltd | Financial | Equity | 3.46% |
| Muthoot Finance Ltd | Financial | Equity | 3.22% |
| HDFC Asset Management Company Ltd | Financial | Equity | 3.15% |
| Pfizer Ltd | Healthcare | Equity | 3.13% |
| Alkem Laboratories Ltd | Healthcare | Equity | 3.04% |
| Abbott India Ltd | Healthcare | Equity | 2.97% |
| Divi's Laboratories Ltd | Healthcare | Equity | 2.90% |
| Aptus Value Housing Finance India Ltd | Financial | Equity | 2.59% |
| Torrent Pharmaceuticals Ltd | Healthcare | Equity | 2.52% |
| UTI Asset Management Company Ltd | Financial | Equity | 2.22% |
| Others CBLO | Unspecified | CBLO | 0.54% |
| Net Payables | Unspecified | Net Payables | -0.05% |
| Name | 6M | 1Y | 3Y | All |
|---|---|---|---|---|
| Fund returns | +7.7% | -5.0% | +8.7% | +12.1% |
| Category average (Equity ELSS) | -0.5% | +2.4% | +16.4% | -- |
| Rank (Equity ELSS) | -- | 28 | 25 | -- |